Bausch Health Companies (BHC) Non Operating Investment Income (2010 - 2014)
Bausch Health Companies (BHC) posted Non Operating Investment Income of $287.1 million for Q4 2014, up 8344.12% sequentially from $3.4 million in Q3 2014.
Bausch Health Companies (BHC) Non Operating Investment Income (2010 - 2014) Analysis & Trends
Bausch Health Companies has reported Non Operating Investment Income for 5 years, with the latest figure at $287.1 million in Q4 2014.
- Quarterly Non Operating Investment Income changed N/A year-over-year to $287.1 million in Q4 2014, while the trailing twelve-month figure through Dec 2015 was $287.1 million (down 2.01% YoY) and the FY2014 annual result came in at $293.0 million, up 4951.72% from the prior year.
- Non Operating Investment Income grew to $287.1 million in Q4 2014 per BHC's latest filing, from $3.4 million in the prior quarter.
- Over five years, Non Operating Investment Income peaked at $287.1 million in Q4 2014 and troughed at -$5.0 million in Q3 2010.
- A 5-year average of $21.2 million and a median of $1.8 million in 2011 frame the typical range for Non Operating Investment Income.
- The sharpest annual moves came in 2012 and 2013: Non Operating Investment Income tumbled 100.17% in 2012, then surged 11242.86% in 2013.
- Over 5 years, Non Operating Investment Income stood at -$5.0 million in 2010, then soared by 99.78% to -$11000.0 in 2011, then surged by 790.91% to $76000.0 in 2012, then soared by 5031.58% to $3.9 million in 2013, then surged by 7261.54% to $287.1 million in 2014.
- According to Business Quant data, Non Operating Investment Income over the past three periods registered $287.1 million, $3.4 million, and $2.5 million for Q4 2014, Q3 2014, and Q2 2014 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Bausch Health Companies | 2.42 Bn | 586.38 Mn | 2.10 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | 287.10 Mn |
| Dec 31, 2014 | 287.10 Mn |
| Sep 30, 2014 | 3.40 Mn |
| Sep 30, 2014 | 3.40 Mn |
| Jun 30, 2014 | 2.50 Mn |
| Jun 30, 2014 | 2.50 Mn |
| Jun 30, 2013 | 3.90 Mn |
| Jun 30, 2013 | 3.90 Mn |
| Mar 31, 2013 | 1.86 Mn |
| Mar 31, 2013 | 1.86 Mn |
| Dec 31, 2012 | 76,000.00 |
| Dec 31, 2012 | 76,000.00 |
| Jun 30, 2012 | -35,000.00 |
| Jun 30, 2012 | -35,000.00 |
| Mar 31, 2012 | 2.06 Mn |
| Mar 31, 2012 | 2.06 Mn |
| Dec 31, 2011 | -11,000.00 |
| Dec 31, 2011 | -11,000.00 |
| Sep 30, 2011 | -140,000.00 |
| Sep 30, 2011 | -140,000.00 |